Proscia raises $37M in Series C financing

Proscia on Tuesday announced it has raised $37 million in a Series C financing round to support the adoption of computational pathology products and scale its commercial operations.

The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, Robo Global, Emerald Development Managers, and Razor’s Edge Ventures.